Mitoconix Bio
Latest round
- Series A
Last raised
- Jun 2017
Total raised
- $20M
Investors
- 5
About Mitoconix Bio
Founded in 2016 and based in Ness Ziona, Israel, Mitoconix Bio Ltd. operates as a biopharmaceutical company that develops mitochondrial health as a disease-modifying therapeutic for neurodegenerative diseases.
Who invested in Mitoconix Bio
5 investors across 1 round
See all investors in Mitoconix Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 27, 2017
Amount
$20M
Investors
Questions about Mitoconix Bio
Who invested in Mitoconix Bio?
Mitoconix Bio has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mitoconix Bio raised?
Mitoconix Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mitoconix Bio last raise money?
Mitoconix Bio's most recent round on record is a Series A, in Jun 2017.
What does Mitoconix Bio do?
Founded in 2016 and based in Ness Ziona, Israel, Mitoconix Bio Ltd.
Where is Mitoconix Bio headquartered?
Mitoconix Bio is headquartered in Israel.
Which VCs invest in companies like Mitoconix Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Mitoconix Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Mitoconix Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.